Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arbor Surgical Technologies was a medical device company focused on developing innovative technologies for heart valve replacement and repair. The company's flagship product was the 3f Enable Aortic Bioprosthesis, a sutureless tissue heart valve designed to simplify surgical implantation and reduce bypass time. Founded in 2002 and based in Irvine, California, the company aimed to improve patient outcomes in cardiac surgery through less invasive and more efficient valve solutions. In 2009, Arbor Surgical Technologies was acquired by Medtronic to bolster its structural heart portfolio. The acquisition allowed Medtronic to integrate sutureless valve technology into its existing line of heart valve products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arbor Surgical Technologies.